160 related articles for article (PubMed ID: 15612370)
1. Tomographic imaging of collagen-mineral interaction: implications for osteogenesis imperfecta.
Landis WJ
Connect Tissue Res; 1995; 31(4):287-90. PubMed ID: 15612370
[TBL] [Abstract][Full Text] [Related]
2. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim).
Grabner B; Landis WJ; Roschger P; Rinnerthaler S; Peterlik H; Klaushofer K; Fratzl P
Bone; 2001 Nov; 29(5):453-7. PubMed ID: 11704498
[TBL] [Abstract][Full Text] [Related]
3. First mouse model for combined osteogenesis imperfecta and Ehlers-Danlos syndrome.
Chen F; Guo R; Itoh S; Moreno L; Rosenthal E; Zappitelli T; Zirngibl RA; Flenniken A; Cole W; Grynpas M; Osborne LR; Vogel W; Adamson L; Rossant J; Aubin JE
J Bone Miner Res; 2014 Jun; 29(6):1412-23. PubMed ID: 24443344
[TBL] [Abstract][Full Text] [Related]
4. The strength of a calcified tissue depends in part on the molecular structure and organization of its constituent mineral crystals in their organic matrix.
Landis WJ
Bone; 1995 May; 16(5):533-44. PubMed ID: 7654469
[TBL] [Abstract][Full Text] [Related]
5. Structural relations between collagen and mineral in bone as determined by high voltage electron microscopic tomography.
Landis WJ; Hodgens KJ; Arena J; Song MJ; McEwen BF
Microsc Res Tech; 1996 Feb; 33(2):192-202. PubMed ID: 8845518
[TBL] [Abstract][Full Text] [Related]
6. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.
Lindahl K; Barnes AM; Fratzl-Zelman N; Whyte MP; Hefferan TE; Makareeva E; Brusel M; Yaszemski MJ; Rubin CJ; Kindmark A; Roschger P; Klaushofer K; McAlister WH; Mumm S; Leikin S; Kessler E; Boskey AL; Ljunggren O; Marini JC
Hum Mutat; 2011 Jun; 32(6):598-609. PubMed ID: 21344539
[TBL] [Abstract][Full Text] [Related]
7. Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy.
Camacho NP; Landis WJ; Boskey AL
Connect Tissue Res; 1996; 35(1-4):259-65. PubMed ID: 9084664
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.
Jacobsen CM; Schwartz MA; Roberts HJ; Lim KE; Spevak L; Boskey AL; Zurakowski D; Robling AG; Warman ML
Bone; 2016 Sep; 90():127-32. PubMed ID: 27297606
[TBL] [Abstract][Full Text] [Related]
9. Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering.
Fratzl P; Paris O; Klaushofer K; Landis WJ
J Clin Invest; 1996 Jan; 97(2):396-402. PubMed ID: 8567960
[TBL] [Abstract][Full Text] [Related]
10. OIM and related animal models of osteogenesis imperfecta.
Shapiro JR; Mcbride DJ; Fedarko NS
Connect Tissue Res; 1995; 31(4):265-8. PubMed ID: 15612365
[TBL] [Abstract][Full Text] [Related]
11. Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice.
Camacho NP; Carroll P; Raggio CL
Calcif Tissue Int; 2003 May; 72(5):604-9. PubMed ID: 12574874
[TBL] [Abstract][Full Text] [Related]
12. Mineral changes in a transgenic mouse model for osteogenesis imperfecta.
Cassella JP; Pereira R; Prockop DJ; Ali SY
Br J Biomed Sci; 1996 Jun; 53(2):108-15. PubMed ID: 8757687
[TBL] [Abstract][Full Text] [Related]
13. Multi-scale analysis of bone chemistry, morphology and mechanics in the oim model of osteogenesis imperfecta.
Bart ZR; Hammond MA; Wallace JM
Connect Tissue Res; 2014 Aug; 55 Suppl 1():4-8. PubMed ID: 25158170
[TBL] [Abstract][Full Text] [Related]
14. A novel transgenic murine model with persistently brittle bones simulating osteogenesis imperfecta type I.
Liu Y; Wang J; Liu S; Kuang M; Jing Y; Zhao Y; Wang Z; Li G
Bone; 2019 Oct; 127():646-655. PubMed ID: 31369917
[TBL] [Abstract][Full Text] [Related]
15. Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility.
Carriero A; Doube M; Vogt M; Busse B; Zustin J; Levchuk A; Schneider P; Müller R; Shefelbine SJ
Bone; 2014 Apr; 61():116-24. PubMed ID: 24373921
[TBL] [Abstract][Full Text] [Related]
16. Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model.
Kuznetsova NV; Forlino A; Cabral WA; Marini JC; Leikin S
Matrix Biol; 2004 May; 23(2):101-12. PubMed ID: 15246109
[TBL] [Abstract][Full Text] [Related]
17. Mineral and organic matrix interaction in normally calcifying tendon visualized in three dimensions by high-voltage electron microscopic tomography and graphic image reconstruction.
Landis WJ; Song MJ; Leith A; McEwen L; McEwen BF
J Struct Biol; 1993; 110(1):39-54. PubMed ID: 8494671
[TBL] [Abstract][Full Text] [Related]
18. Collagen (I) homotrimer potentiates the osteogenesis imperfecta (oim) mutant allele and reduces survival in male mice.
Lee KJ; Rambault L; Bou-Gharios G; Clegg PD; Akhtar R; Czanner G; van 't Hof R; Canty-Laird EG
Dis Model Mech; 2022 Sep; 15(9):. PubMed ID: 36106514
[TBL] [Abstract][Full Text] [Related]
19. [Research progress on pathology of osteogenesis imperfecta].
Li H; Han JX; Lu YQ
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):780-3. PubMed ID: 24447563
[No Abstract] [Full Text] [Related]
20. Properties of collagen in OIM mouse tissues.
Sims TJ; Miles CA; Bailey AJ; Camacho NP
Connect Tissue Res; 2003; 44 Suppl 1():202-5. PubMed ID: 12952198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
